Chris Brinzey joined Westwicke Partners in February 2015 as a Managing Director and leads the Boston office, focusing on helping clients in the biotechnology and life sciences, specialty pharmaceuticals, and healthcare services areas.
Chris has over 20 years’ experience working within the financial services industry, both as a sell-side and a buy-side analyst. Prior to joining Westwicke, Chris was a Senior Vice President of Research and a member of the Portfolio Management team at Tekla Capital Management (formerly Hambrecht & Quist Capital Management), which manages $2.5 billion in assets.
Chris has also served as a Vice President at Advest, a full service regional investment bank, where he started the healthcare information technology practice, publishing thematic and monthly industry and company reports on the Healthcare Information Technology sector, including thought-leadership pieces on Internet and mobile healthcare technologies.
Chris has an MBA from Northeastern University and holds a BA in psychology from Hobart College.
